Ocugen (OCGN) Shares Outstanding (Weighted Average) (2014 - 2026)

Ocugen has reported Shares Outstanding (Weighted Average) for 13 years, with the latest figure at $327.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 12.17% year-over-year to $327.5 million; the trailing twelve-month figure through Mar 2026 stood at $327.5 million (up 12.17% YoY), and the FY2025 full-year result was $300.2 million, up 49928.0% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $327.5 million, up from $20.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $327.5 million in Q1 2026, with the low at $54745.0 in Q1 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $185.6 million across 5 years, with a median of $216.6 million in 2022.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Weighted Average) tumbled 99.98% — and 2025, when it soared 540709.78%.
• Ocugen's Shares Outstanding (Weighted Average) stood at $214.6 million in 2022, then climbed by 13.85% to $244.3 million in 2023, then sank by 99.75% to $600000.0 in 2024, then soared by 3333.33% to $20.6 million in 2025, then soared by 1490.02% to $327.5 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $327.5 million (Q1 2026), $20.6 million (Q4 2025), and $296.1 million (Q3 2025), per Business Quant data.